The Human Genome Project is one of the largest and most ambitious scientific initiatives ever undertaken. It was made possible by DNA sequencing technologies, which allowed researchers to map the human genome fully. The discoveries stemming from this project have greatly aided basic and biomedical research.

Next-generation sequencing (NGS), also known as short-read sequencing, is a powerful and highly effective method for studying DNA and RNA. By analyzing nucleic acid fragments typically ranging from 50 to 600 base pairs, this technique provides valuable insight into DNA and RNA structure, modifications, variations and gene expression profiles. Since its inception, NGS has been extensively utilized in the Human Genome Project and has undergone significant advancements in sequencing depth, accuracy, specificity and throughput.

One of the most significant benefits of NGS is its ability to analyze massive amounts of genomic data, which was previously impossible with traditional sequencing methods. With its high throughput, NGS has enabled researchers to study multiple genomes simultaneously, accelerating scientific discovery. Additionally, NGS has played a critical role in personalized medicine, allowing for the identification of genetic variations that can lead to the development of targeted therapies. Overall, NGS has revolutionized the field of genomics and continues to pave the way for discoveries in molecular biology and personalized medicine.

Next-generation sequencing workflow

Next-generation sequencing workflows vary based on the selected sample type or library preparation kit. However, common steps are followed when going from sample to answer.

See how Danaher Life Sciences can help

Talk to an expert

Biomedical and Industrial Applications of Next-Generation Sequencing

NGS (also called short-read sequencing) is a cost-effective method used for genomic or transcriptomic sequencing with a wide range of applications. Here are a few examples of how NGS has benefited biomedical and industrial users.

Next-Generation Sequencing Approaches

NGS approaches can be classified into the following ways based on the chemistry involved:

Challenges and Limitations

Short-read sequencing has become increasingly popular in research and industrial applications due to its faster and more cost-effective nature. However, the main limitation of this technology is the read length. Third-generation sequencing (also called long-read sequencing) has been developed to overcome this limitation. Long-read sequencing allows for generating reads that can be in the megabase pair lengths.

Shorter reads can lead to uneven coverage of genomic regions, particularly those with repeat sequences, such as GC- or AT-rich sequences. Furthermore, short-read sequencing can have difficulty accessing certain parts of the genome, such as telomeric regions, making de novo genome assembly challenging. This aspect prompted researchers with the Human Genome Project to adopt long-read sequencing to finish sequencing the human genome.

Recent Advancements

Short-read sequencing is a widely used technique in molecular biology and genomics, and developers have been continually innovating to improve the accuracy, sensitivity, coverage and throughput while lowering the cost of the process. Recent improvements have focused on data acquisition and analysis, with cloud computing and artificial intelligence shortening the time required to analyze data while improving variant calling and annotation through data training models. The increased access to greater parts of the genome through improved library preparation methods has also led to increased data integrity.

In addition, labs that have historically found short-read sequencing cost-prohibitive now have access to these technologies. Nanopore-based sequencing and single-molecule real-time sequencing, which were previously associated with long-read sequencing, are directly being applied to shorter fragments. These technologies provide accuracy and specificity while allowing longer read lengths and better coverage of complex genomic regions.

FAQs

What is short-read sequencing?

Short-read sequencing is a next-generation sequencing technology that sequences nucleic acid fragments of 50-600 base pairs.

What is the difference between short-read and long-read sequencing?

Short-read and long-read sequencing differ mainly in the length of nucleic acid fragments they can accommodate. Short-read sequencing focuses on fragments that are 50-600 bases long, while long-read sequencing can handle fragments ranging from 1 Kbps to several megabase pairs. Long-read sequencing provides better accessibility to complex genomic regions, such as telomeric or acrocentric regions. It offers better coverage of tandem repeat sequences, which short-read sequencing cannot achieve. However, short-read sequencing is more accurate and sensitive, has a higher throughput, and is cost-efficient.

What is short-read RNA sequencing?

RNA-seq is a next-generation sequencing approach to profile the transcriptome (mRNA). RNA-seq can detect, identify and quantify transcripts in biological samples.

What are sequencing reads?

Sequencing reads refer to the number of base pair sequences obtained after sequencing the nucleic acid fragment of interest from a biological sample.

See how Danaher Life Sciences can help

Talk to an expert

recent-articles